William H. Stoothoff, Ph.D. - Publications
Affiliations: | 2004 | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Neuroscience BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2009 | Spires-Jones TL, Stoothoff WH, de Calignon A, Jones PB, Hyman BT. Tau pathophysiology in neurodegeneration: a tangled issue. Trends in Neurosciences. 32: 150-9. PMID 19162340 DOI: 10.1016/J.Tins.2008.11.007 | 0.385 | |||
2008 | Stoothoff WH, Bacskai BJ, Hyman BT. Monitoring tau-tubulin interactions utilizing second harmonic generation in living neurons. Journal of Biomedical Optics. 13: 064039. PMID 19123685 DOI: 10.1117/1.3050422 | 0.453 | |||
2005 | Stoothoff WH, Johnson GV. Tau phosphorylation: physiological and pathological consequences. Biochimica Et Biophysica Acta. 1739: 280-97. PMID 15615646 DOI: 10.1016/J.Bbadis.2004.06.017 | 0.662 | |||
2005 | Stoothoff WH, Cho JH, McDonald RP, Johnson GV. FRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylation. The Journal of Biological Chemistry. 280: 270-6. PMID 15522877 DOI: 10.1074/Jbc.M410061200 | 0.717 | |||
2004 | Johnson GV, Stoothoff WH. Tau phosphorylation in neuronal cell function and dysfunction. Journal of Cell Science. 117: 5721-9. PMID 15537830 DOI: 10.1242/Jcs.01558 | 0.674 | |||
2002 | Stoothoff WH, Bailey CD, Mi K, Lin SC, Johnson GV. Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta. Journal of Neurochemistry. 83: 904-13. PMID 12421363 DOI: 10.1046/J.1471-4159.2002.01197.X | 0.369 | |||
2001 | Stoothoff WH, Johnson GVW. Hyperosmotic stress-induced apoptosis and Tau phosphorylation in human neuroblastoma cells Journal of Neuroscience Research. 65: 573-582. PMID 11550225 DOI: 10.1002/Jnr.1187 | 0.631 | |||
Show low-probability matches. |